Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase

por Jathal, Maitreyee K., Steele, Thomas M., Siddiqui, Salma, Mooso, Benjamin A., D’Abronzo, Leandro S., Drake, Christiana M., Whang, Young E., Ghosh, Paramita M.
Publicado 2019

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

por Jathal, Maitreyee K., Siddiqui, Salma, Vasilatis, Demitria M., Durbin Johnson, Blythe P., Drake, Christiana, Mooso, Benjamin A., D’Abronzo, Leandro S., Batra, Neelu, Mudryj, Maria, Ghosh, Paramita M.
Publicado 2023